Mylle, Sofie
Grine, Lynda
Speeckaert, Reinhart http://orcid.org/0000-0002-9421-3546
Lambert, Jo L.W.
van Geel, Nanja
Funding for this research was provided by:
FWO (1831512N)
Article History
First Online: 12 July 2018
Compliance with Ethical Standards
:
: The work presented was performed without funding.
: Sofie Mylle, Reinhart Speeckaert and Nanja van Geel declare no conflict of interest. Jo Lambert has received unrestricted educational grants, board and speaker’s fees from AbbVie, Celgene, Eli Lilly, Janssen Cilag, Leo Pharma, Novartis, Pfizer, and UCB. Lynda Grine has received a speaker’s fee from AbbVie.